Middleton G, Yang Y, Campbell CD, Andre T, et al. BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer. Clin Cancer Res 2020 Feb 11. pii: 1078-0432.CCR-19-3579.
PMID: 32047001